Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2025-11-03 00:00:00 ET · period of report 2025-10-30 · accession 0001881190-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-03 | 2025-10-30 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $25.01 | +200 | 61.9K | +0.3% | +$5,002 |
| D | 2025-11-03 | 2025-10-30 | AGIO | Gheuens Sarah | Chief Medical Off | S - Sale+OE | $43.81 | -200 | 61.7K | -0.3% | -$8,762 |
| D | 2025-11-03 | 2025-10-30 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | -200 | 28.6K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-10-30 | M | A | 200 | $25.01 | 61,927 | D | — | — | |
| 2 | Common | Common stock | 2025-10-30 | S | D | 200 | $43.81 | 61,727 | D | — | — | |
| 3 | Derivative | Stock options (right to buy) | 2025-10-30 | M | D | 200 | $0.00 | 28,584 | D | $25.01 · — to 2033-03-01 | 200 Common stock | (F2) This option was originally granted on March 1, 2023 for the purchase of 44,000 shares of common stock. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. |